Skip to main content
Top
Published in: International Urology and Nephrology 1/2019

01-01-2019 | Urology - Original Paper

Effect of pregnancy on the cholinergic responses of the bladder: role of acetylcholinesterase

Author: Seham Mustafa

Published in: International Urology and Nephrology | Issue 1/2019

Login to get access

Abstract

Objectives

Pregnancy is associated with many functional changes of the urinary bladder. It was reported that most of healthy women complain from urinary symptoms during pregnancy. The parasympathetic system is mainly mediating bladder emptying. The aim of the study is to investigate the cholinergic effect and the role of acetylcholinesterase in the bladder during pregnancy.

Methods

Sixteen rats were used in the present study as control group (non-pregnant) and pregnant group (18–20 days pregnant). Isolated urinary smooth muscle strips were suspended in organ baths filled with Krebs’ solution for isometric tension recording.

Results

Electric field stimulation (EFS), (0.1–40 Hz), of the control and pregnant bladder preparations produced frequency-dependent contractions. Atropine (1 µM) inhibited EFS-induced contractions in the two groups by 65% and 50% respectively indicating the response of cholinergic innervation. Neostigmine significantly enhanced EFS responses, confirming its selectivity for inhibiting acetylcholinesterase which is responsible for termination of acetylcholine. Concentration–response curves for acetylcholine were reduced in pregnant group than control. Concentration–response curves for ATP were increased in pregnant group than control. Neostigmine augmented concentration–response curves for acetylcholine in control and pregnant groups. The effect of neostigmine on acetylcholine contractile responses in pregnancy group was higher than in control.

Conclusions

Urinary bladder dysfunction during pregnancy might be due to augmentation of acetylcholinesterase effect. This will lead to the decrease in response to cholinergic stimuli. New pharmaceutical drugs specifically affecting the enzyme in the bladder can help in avoiding the unpleasant urinary symptoms during pregnancy.
Literature
1.
go back to reference Burnstock G (2014) Purinergic signalling in the urinary tract in health and disease. Purinergic Signal 10(1):103–155CrossRefPubMed Burnstock G (2014) Purinergic signalling in the urinary tract in health and disease. Purinergic Signal 10(1):103–155CrossRefPubMed
2.
go back to reference Lawrence GW, Aoki R, Dolly O (2010) Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin A consistent with co-release of transmitters from efferent fibers. J Pharmacol Exp Ther 334:1080–1086CrossRefPubMed Lawrence GW, Aoki R, Dolly O (2010) Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin A consistent with co-release of transmitters from efferent fibers. J Pharmacol Exp Ther 334:1080–1086CrossRefPubMed
3.
go back to reference Levin RM, Longhurst PA, Kato K, Elbadawi A, Wein AJ, McGuire EJ (1990) Comparative physiology and pharmacology of the cat and rabbit urinary bladder. J Urol 143(4):848–852CrossRefPubMed Levin RM, Longhurst PA, Kato K, Elbadawi A, Wein AJ, McGuire EJ (1990) Comparative physiology and pharmacology of the cat and rabbit urinary bladder. J Urol 143(4):848–852CrossRefPubMed
4.
go back to reference Igawa Y, Mattiasson A, Andersson KE (1993) Functional importance of cholinergic and purinergic neurotransmission for micturition contraction in the normal, unanaesthetized rat. Br J Pharmachol 109:473–479CrossRef Igawa Y, Mattiasson A, Andersson KE (1993) Functional importance of cholinergic and purinergic neurotransmission for micturition contraction in the normal, unanaesthetized rat. Br J Pharmachol 109:473–479CrossRef
5.
go back to reference Ward TR, Ferris DJ, Tilson HA, Mundy WR (1993) Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Toxicol Appl Pharmacol 122:300–307CrossRefPubMed Ward TR, Ferris DJ, Tilson HA, Mundy WR (1993) Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Toxicol Appl Pharmacol 122:300–307CrossRefPubMed
7.
go back to reference Tong YC, Hung YC, Lin JS, Hsu CT, Cheng JT (1995) Effects of pregnancy and progesterone on autonomic function in the rat urinary bladder. Pharmacology 50(3):192–200CrossRefPubMed Tong YC, Hung YC, Lin JS, Hsu CT, Cheng JT (1995) Effects of pregnancy and progesterone on autonomic function in the rat urinary bladder. Pharmacology 50(3):192–200CrossRefPubMed
8.
go back to reference Elliott RA, Castleden CM (1994) Effect of progestogens and oestrogens on the contractile response of rat detrusor muscle to electrical field stimulation. Clin Sci (London) 87(3):337–342CrossRef Elliott RA, Castleden CM (1994) Effect of progestogens and oestrogens on the contractile response of rat detrusor muscle to electrical field stimulation. Clin Sci (London) 87(3):337–342CrossRef
9.
go back to reference Knight GE, Burnstock G (2004) The effect of pregnancy and the oestrus cycle on purinergic and cholinergic responses of the rat urinary bladder. Neuropharmacology 46(7):1049–1056CrossRefPubMed Knight GE, Burnstock G (2004) The effect of pregnancy and the oestrus cycle on purinergic and cholinergic responses of the rat urinary bladder. Neuropharmacology 46(7):1049–1056CrossRefPubMed
10.
go back to reference Levin RM, Zderic SA, Ewalt DH, Duckett JW, Wein AJ (1991) Effects of pregnancy on muscarinic receptor density and function in the rabbit urinary bladder. Pharmacology 43(2):69–77CrossRefPubMed Levin RM, Zderic SA, Ewalt DH, Duckett JW, Wein AJ (1991) Effects of pregnancy on muscarinic receptor density and function in the rabbit urinary bladder. Pharmacology 43(2):69–77CrossRefPubMed
11.
go back to reference Hoyle CH (1994) Non-adrenergic, non-cholinergic control of the urinary bladder. World J Urol 12(5):233–244CrossRefPubMed Hoyle CH (1994) Non-adrenergic, non-cholinergic control of the urinary bladder. World J Urol 12(5):233–244CrossRefPubMed
12.
go back to reference Mustafa S (2018) Effect of pregnancy on cooling tone and rhythmic contractions of the rat urinary bladder. Int Urol Nephrol 50:833–838CrossRefPubMed Mustafa S (2018) Effect of pregnancy on cooling tone and rhythmic contractions of the rat urinary bladder. Int Urol Nephrol 50:833–838CrossRefPubMed
13.
go back to reference Iacovou JW, Hill SJ, Birmingham AT (1990) Agonist-induced contraction and accumulation of inositol phosphates in the guinea-pig detrusor: evidence that muscarinic and purinergic receptors raise intracellular calcium by different mechanisms. J Urol 144(3):775–779CrossRefPubMed Iacovou JW, Hill SJ, Birmingham AT (1990) Agonist-induced contraction and accumulation of inositol phosphates in the guinea-pig detrusor: evidence that muscarinic and purinergic receptors raise intracellular calcium by different mechanisms. J Urol 144(3):775–779CrossRefPubMed
14.
go back to reference Wuest M, Hiller N, Braeter M, Hakenberg OW, Wirth MP, Ravens U (2007) Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol 22(1–3):180–189 565(CrossRef Wuest M, Hiller N, Braeter M, Hakenberg OW, Wirth MP, Ravens U (2007) Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol 22(1–3):180–189 565(CrossRef
15.
go back to reference Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16(5):433–440CrossRefPubMed Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16(5):433–440CrossRefPubMed
16.
go back to reference Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64(3):445–475CrossRefPubMed Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64(3):445–475CrossRefPubMed
17.
go back to reference Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413–492PubMed Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413–492PubMed
19.
go back to reference Mokrý J, Jakubesov M, Svihra J, Urdzik J, Hudec M, Nosalova G, Kliment J (2005) Reactivity of urinary bladder smooth muscle in guinea pigs to acetylcholine and carbacholeparticipation of acetylcholinesterase. Physiol Res 54:453–458PubMed Mokrý J, Jakubesov M, Svihra J, Urdzik J, Hudec M, Nosalova G, Kliment J (2005) Reactivity of urinary bladder smooth muscle in guinea pigs to acetylcholine and carbacholeparticipation of acetylcholinesterase. Physiol Res 54:453–458PubMed
20.
go back to reference Stallard S, Prescott S (1988) Postoperative urinary retention in general surgical patients. Br J Surg 75(11):1141–1143CrossRefPubMed Stallard S, Prescott S (1988) Postoperative urinary retention in general surgical patients. Br J Surg 75(11):1141–1143CrossRefPubMed
21.
go back to reference Mustafa S (2014) Reactivity of diabetic urinary bladder to the cholinesterase inhibitor neostigmine. Urology 84(6):1549.e1–1549.e5CrossRef Mustafa S (2014) Reactivity of diabetic urinary bladder to the cholinesterase inhibitor neostigmine. Urology 84(6):1549.e1–1549.e5CrossRef
Metadata
Title
Effect of pregnancy on the cholinergic responses of the bladder: role of acetylcholinesterase
Author
Seham Mustafa
Publication date
01-01-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-2032-5

Other articles of this Issue 1/2019

International Urology and Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.